Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8825166 Multiple-symptom medical treatment with roving-based neurostimulation
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
0
Date Filed
January 23, 2007
0
Date of Patent
September 2, 2014
0
Patent Application Number
11626372
0
Patent Citations Received
US Patent 12115365 Device and method for unattended treatment of a patient
0
US Patent 12020797 Insulin and pramlintide delivery systems, methods, and devices
0
US Patent 12076576 Methods and devices for aesthetic treatment of biological structures by radiofrequency and magnetic energy
0
US Patent 12109426 Aesthetic method of biological structure treatment by magnetic field
0
US Patent 12109427 Aesthetic method of biological structure treatment by magnetic field
0
US Patent 11759638 Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods
US Patent 11786731 Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods
US Patent 11878145 Closed loop control of physiological glucose
0
US Patent 11878162 Systems and methods for tissue treatment
0
US Patent 11878167 Device and method for unattended treatment of a patient
0
•••
Patent Inventor Names
John Sasha John
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
8825166
0
Patent Primary Examiner
Amanda Patton
0
Find more entities like US Patent 8825166 Multiple-symptom medical treatment with roving-based neurostimulation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE